323 related articles for article (PubMed ID: 16306086)
1. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action.
Harrington WR; Kim SH; Funk CC; Madak-Erdogan Z; Schiff R; Katzenellenbogen JA; Katzenellenbogen BS
Mol Endocrinol; 2006 Mar; 20(3):491-502. PubMed ID: 16306086
[TBL] [Abstract][Full Text] [Related]
2. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors.
Madak-Erdogan Z; Kieser KJ; Kim SH; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
Mol Endocrinol; 2008 Sep; 22(9):2116-27. PubMed ID: 18617595
[TBL] [Abstract][Full Text] [Related]
3. Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus.
Yang LC; Zhang QG; Zhou CF; Yang F; Zhang YD; Wang RM; Brann DW
PLoS One; 2010 May; 5(5):e9851. PubMed ID: 20479872
[TBL] [Abstract][Full Text] [Related]
4. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity.
Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura A; Lawrence J; Berstein L; Yue W
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S61-73. PubMed ID: 16113100
[TBL] [Abstract][Full Text] [Related]
5. Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells.
Song RX; Santen RJ; Kumar R; Adam L; Jeng MH; Masamura S; Yue W
Mol Cell Endocrinol; 2002 Jul; 193(1-2):29-42. PubMed ID: 12160999
[TBL] [Abstract][Full Text] [Related]
6. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.
Rai D; Frolova A; Frasor J; Carpenter AE; Katzenellenbogen BS
Mol Endocrinol; 2005 Jun; 19(6):1606-17. PubMed ID: 15831524
[TBL] [Abstract][Full Text] [Related]
7. The role of adapter protein Shc in estrogen non-genomic action.
Zhang Z; Kumar R; Santen RJ; Song RX
Steroids; 2004 Aug; 69(8-9):523-9. PubMed ID: 15288764
[TBL] [Abstract][Full Text] [Related]
8. Identification of estrogen receptor ligands leading to activation of non-genomic signaling pathways while exhibiting only weak transcriptional activity.
Wessler S; Otto C; Wilck N; Stangl V; Fritzemeier KH
J Steroid Biochem Mol Biol; 2006 Jan; 98(1):25-35. PubMed ID: 16203130
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase.
Greger JG; Fursov N; Cooch N; McLarney S; Freedman LP; Edwards DP; Cheskis BJ
Mol Cell Biol; 2007 Mar; 27(5):1904-13. PubMed ID: 17194752
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.
Gaben AM; Saucier C; Bedin M; Redeuilh G; Mester J
Mol Endocrinol; 2004 Nov; 18(11):2700-13. PubMed ID: 15297603
[TBL] [Abstract][Full Text] [Related]
12. Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells.
Marino M; Acconcia F; Bresciani F; Weisz A; Trentalance A
Mol Biol Cell; 2002 Oct; 13(10):3720-9. PubMed ID: 12388769
[TBL] [Abstract][Full Text] [Related]
13. Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer.
Santen RJ; Song RX; Zhang Z; Yue W; Kumar R
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):337S-45S. PubMed ID: 14734489
[TBL] [Abstract][Full Text] [Related]
14. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.
Fox EM; Andrade J; Shupnik MA
Steroids; 2009 Jul; 74(7):622-7. PubMed ID: 18996136
[TBL] [Abstract][Full Text] [Related]
15. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
16. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions.
Björnström L; Sjöberg M
Mol Endocrinol; 2002 Oct; 16(10):2202-14. PubMed ID: 12351686
[TBL] [Abstract][Full Text] [Related]
17. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
[TBL] [Abstract][Full Text] [Related]
18. Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells.
Chang M; Peng KW; Kastrati I; Overk CR; Qin ZH; Yao P; Bolton JL; Thatcher GR
Endocrinology; 2007 Oct; 148(10):4793-802. PubMed ID: 17584965
[TBL] [Abstract][Full Text] [Related]
19. Signaling from the membrane via membrane estrogen receptor-alpha: estrogens, xenoestrogens, and phytoestrogens.
Watson CS; Bulayeva NN; Wozniak AL; Finnerty CC
Steroids; 2005; 70(5-7):364-71. PubMed ID: 15862819
[TBL] [Abstract][Full Text] [Related]
20. In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro.
Otto C; Fuchs I; Altmann H; Klewer M; Schwarz G; Bohlmann R; Nguyen D; Zorn L; Vonk R; Prelle K; Osterman T; Malmström C; Fritzemeier KH
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):95-100. PubMed ID: 18606537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
